Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-030037

CEO and CFO bought 1,000 shares at $9.97 ($9,970)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2023-08-22 Purchase +1,000 $9.97 $9,970 5,291,177 D
Open-market purchases · 1,000 sh · avg $9.97 · $9,970
Loading xslF345X05/ownership.xml…